News
The obesity drug market is entering a new phase as pharmaceutical companies race to develop oral therapies, combination treatments and next-generation medicines. With forecasts pointing to a $100 billion annual market, competition is shifting from two dominant players to a much broader field of innovators.
Medical device sales representatives using AI are significantly more likely to meet or exceed quota, according to new research. While most teams currently use AI for administrative tasks such as email drafting and meeting summaries, the greatest opportunity lies in applying AI to commercial intelligence, account planning and sales strategy.
UnitedHealth Group’s second-quarter earnings beat Wall Street expectations as tighter cost controls and improved margins helped restore investor confidence. The stronger results prompted higher full-year guidance and suggested the healthcare giant’s turnaround strategy is beginning to gain traction despite ongoing industry challenges.
Nearly 9.6 million US adults have traveled overseas for dental treatment, highlighting how rising costs and insurance limitations are changing the way Americans access oral healthcare.
Microsoft and Mayo Clinic have launched a new collaboration to develop healthcare-focused AI models that could reshape clinical workflows, research and patient care. The initiative reflects a broader industry shift toward specialized AI systems designed specifically for medicine.
Healthcare organizations have embraced AI to improve efficiency, reduce administrative burden and support patient engagement. New survey data shows adoption is growing among both patients and clinicians, yet a widening trust gap threatens to limit AI’s full potential. The organizations that succeed will be those that combine trusted data, human oversight and clinical-grade governance.
Biotech and pharmaceutical dealmaking has surpassed $106 billion in 2026, driven by the search for innovative therapies in oncology, obesity, rare diseases and precision medicine. For healthcare leaders, the trend highlights how the next generation of treatments is increasingly moving from biotech laboratories into global healthcare markets through strategic acquisitions.
NYU Langone Health’s proposed academic medical center in Melville represents one of the largest healthcare investments on Long Island in decades. Combining patient care, medical education and research, the development could reshape healthcare access, workforce development and regional economic growth.
Oscar Health’s latest earnings suggest the Affordable Care Act marketplace has entered a more mature and profitable phase as enrollment growth and consumer demand continue rising.
Healthcare affordability in the US is becoming an economic problem as rising costs, chronic disease and medical debt place pressure on households, employers and public budgets.
Amazon Pharmacy is expanding access to oral GLP-1 medications through same-day delivery and prescription kiosks inside One Medical clinics, signaling a broader shift toward logistics-driven healthcare delivery.
Healthcare bankruptcies are climbing again in 2026 as providers face rising labor costs, reimbursement disputes and refinancing pressure across the sector.
